Researchers looked at how doxycycline affects patients diagnosed with bancroftian filariasis. They compared the effects of the medication against intensified hygiene measures alone. The study specifically measured the number of Wolbachia bacteria found within microfilaria, as well as the overall count of microfilariae and the reduction of lymphedema.
The results showed that doxycycline significantly reduced the number of Wolbachia per microfilaria. However, the data regarding the actual count of microfilariae was not robust and did not show a consistent result. While the medication targets the bacteria, the study suggests it has a limited role in reducing the physical swelling known as lymphedema.
Patients taking the medication reported some side effects, specifically vomiting. Because the data for microfilarial counts were inconsistent, the results are not yet clear enough to change standard care. Patients should talk to their doctors about how these findings might apply to their specific treatment plan.
